Antinori A - Search Results

1

Interpretation systems for genotypic drug resistance of HIV-1.

De Luca A, Antinori A, Di Giambenedetto S, Cingolani A, Colafigli M, Perno CF, Cauda R. De Luca A, et al. Among authors: antinori a. Scand J Infect Dis Suppl. 2003;106:29-34. doi: 10.1080/03008870310009623. Scand J Infect Dis Suppl. 2003. PMID: 15000579 Review.

2

Usefulness of monitoring HIV drug resistance and adherence in individuals failing highly active antiretroviral therapy: a randomized study (ARGENTA).

Cingolani A, Antinori A, Rizzo MG, Murri R, Ammassari A, Baldini F, Di Giambenedetto S, Cauda R, De Luca A. Cingolani A, et al. Among authors: antinori a. AIDS. 2002 Feb 15;16(3):369-79. doi: 10.1097/00002030-200202150-00008. AIDS. 2002. PMID: 11834948 Clinical Trial.

3

Highly active antiretroviral therapy and allogeneic CD34(+) peripheral blood progenitor cells transplantation in an HIV/HCV coinfected patient with acute myeloid leukemia.

Sorà F, Antinori A, Piccirillo N, De Luca A, Chiusolo P, Cingolani A, Laurenti L, Rutella S, Ortona L, Leone G, Sica S. Sorà F, et al. Among authors: antinori a. Exp Hematol. 2002 Mar;30(3):279-84. doi: 10.1016/s0301-472x(01)00793-7. Exp Hematol. 2002. PMID: 11882366 Free article.

4

Kinetics of CD4 cells after discontinuation of antiretroviral therapy in patients with virological failure and a CD4 cell count greater than 500 cells/microl.

Mussini C, Bugarini R, Perno CF, Antinori A, Borghi V, Bertoli A, D'Arrigo R, Bedini A, Mongiardo N, Cossarizza A, Esposito R. Mussini C, et al. Among authors: antinori a. AIDS. 2002 Jul 26;16(11):1551-4. doi: 10.1097/00002030-200207260-00013. AIDS. 2002. PMID: 12131194 Clinical Trial.

5

Cross-resistance among nonnucleoside reverse transcriptase inhibitors limits recycling efavirenz after nevirapine failure.

Antinori A, Zaccarelli M, Cingolani A, Forbici F, Rizzo MG, Trotta MP, Di Giambenedetto S, Narciso P, Ammassari A, Girardi E, De Luca A, Perno CF. Antinori A, et al. AIDS Res Hum Retroviruses. 2002 Aug 10;18(12):835-8. doi: 10.1089/08892220260190308. AIDS Res Hum Retroviruses. 2002. PMID: 12201905

6

A genotypic drug resistance interpretation algorithm that significantly predicts therapy response in HIV-1-infected patients.

Van Laethem K, De Luca A, Antinori A, Cingolani A, Perna CF, Vandamme AM. Van Laethem K, et al. Among authors: antinori a. Antivir Ther. 2002 Jun;7(2):123-9. Antivir Ther. 2002. PMID: 12212924

7

Factors influencing virological response to antiretroviral drugs in cerebrospinal fluid of advanced HIV-1-infected patients.

Antinori A, Giancola ML, Grisetti S, Soldani F, Alba L, Liuzzi G, Amendola A, Capobianchi M, Tozzi V, Perno CF. Antinori A, et al. AIDS. 2002 Sep 27;16(14):1867-76. doi: 10.1097/00002030-200209270-00003. AIDS. 2002. PMID: 12351946

8

Coinfection with hepatitis viruses and outcome of initial antiretroviral regimens in previously naive HIV-infected subjects.

De Luca A, Bugarini R, Lepri AC, Puoti M, Girardi E, Antinori A, Poggio A, Pagano G, Tositti G, Cadeo G, Macor A, Toti M, D'Arminio Monforte A; Italian Cohort Naive Antiretrovirals Study Group. De Luca A, et al. Among authors: antinori a. Arch Intern Med. 2002 Oct 14;162(18):2125-32. doi: 10.1001/archinte.162.18.2125. Arch Intern Med. 2002. PMID: 12374521

9

Virologic correlates of adherence to antiretroviral medications and therapeutic failure.

Perno CF, Ceccherini-Silberstein F, De Luca A, Cozzi-Lepri A, Gori C, Cingolani A, Bellocchi MC, Trotta MP, Piano P, Forbici F, Scasso A, Vullo V, d'Arminio Monforte A, Antinori A; AdICoNA Study Group. Perno CF, et al. Among authors: antinori a. J Acquir Immune Defic Syndr. 2002 Dec 15;31 Suppl 3:S118-22. doi: 10.1097/00126334-200212153-00006. J Acquir Immune Defic Syndr. 2002. PMID: 12562033 Review.

10

Discontinuation of secondary prophylaxis for Pneumocystis carinii pneumonia in human immunodeficiency virus-infected patients: a randomized trial by the CIOP Study Group.

Mussini C, Pezzotti P, Antinori A, Borghi V, Monforte Ad, Govoni A, De Luca A, Ammassari A, Mongiardo N, Cerri MC, Bedini A, Beltrami C, Ursitti MA, Bini T, Cossarizza A, Esposito R; Changes in Opportunistic Prophylaxis (CIOP) Study Group. Mussini C, et al. Among authors: antinori a. Clin Infect Dis. 2003 Mar 1;36(5):645-51. doi: 10.1086/367659. Epub 2003 Feb 12. Clin Infect Dis. 2003. PMID: 12594647 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

899 results

Search Page